Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell TransplantationMichaël Philippe, Catherine Rioufol, Florence Ranchon et al.|Transplantation and Cellular Therapy|2015Cited by 79
Immunosuppression medication adherence after allogeneic hematopoietic stem cell transplant: Impact of a specialized clinical pharmacy programFlorent Charra, Florence Ranchon, Chloé Herledan et al.|Journal of Oncology Pharmacy Practice|2021Cited by 10
Epstein-Barr Virus (EBV) Reactivation, Its Treatment with Rituximab and Their Impact on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological MalignanciesMauricette Michallet, Franck‐Emmanuel Nicolini, Mohamad Sobh et al.|Blood|2016Cited by 4
Tacrolimus Extended Release Formulation Given As An Alternative To Ciclosporine A In Case Of Renal Impairment After Allogeneic HSCT: Results From a Prospective Pilot StudyMarie Y. Detrait, Fiorenza Barraco, Stéphane Morisset et al.|Blood|2013Cited by 0
Tacrolimus Extended Release could be an Alternative to the use of Cyclosporine after Allogeneic HSCT in case of Renal Impairment due to Cyclosporine: A Prospective pilot study from two centers in FranceMarie Y. Detrait, Fiorenza Barraco, Stéphane Morisset et al.|Transplantation Research Journal|2017Cited by 0